Diagnostic parameters for serum APN/CD13, CA19-9, or the combination of APN/CA19-9, for the differentiation of pancreatic cancer (or early pancreatic cancer) from benign pancreatic tumors, chronic pancreatitis and healthy controls. This evidence concerns the gene ANPEP and pancreatic neoplasm.